Fertility Preservation for Cancer Patients

  • Suneeta Senapati
  • Clarisa R. Gracia


Patients exposed to gonadotoxic cancer treatments are at risk for impaired future fertility. Due to improvements in long-term survival, fertility preservation has become increasingly important to both patients and practitioners. This chapter reviews the risks of infertility associated with various cancer treatments and fertility preservation options for both male and female patients, as well as considerations for pregnancy and survivorship care after cancer diagnosis and treatment.


Ovarian Reserve Fertility Preservation Childhood Cancer Survivor Control Ovarian Hyperstimulation Embryo Cryopreservation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute; 2009. Available from
  2. 2.
    Bhatia M, Walters MC. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant. 2008;41(2):109–17.PubMedCrossRefGoogle Scholar
  3. 3.
    Henes M, Henes JC, Neunhoeffer E, et al. Fertility preservation methods in young women with systemic lupus erythematosus prior to cytotoxic therapy: experiences from the FertiPROTEKT network. Lupus. 2012;21(9):953–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Hsieh MM, Kang EM, Fitzhugh CD, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med. 2009;361(24):2309–17.PubMedCrossRefGoogle Scholar
  5. 5.
    Letourneau JM, Ebbel EE, Katz PP, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012;118(6):1710–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917–31.PubMedCrossRefGoogle Scholar
  7. 7.
    Practice Committee of American Society for Reproductive Medicine: Practice Committee for Society of Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2008;90(5 Suppl):S241–6.Google Scholar
  8. 8.
    Johnson J, Bagley J, Skaznik-Wikiel M, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell. 2005;122(2):303–15.PubMedCrossRefGoogle Scholar
  9. 9.
    Strauss JF, Barbieri RL. Yen and Jaffe’s reproductive endocrinology: physiology, pathophysiology, and clinical management. 6th ed. Philadelphia, PA: Saunders Elsevier; 2009.Google Scholar
  10. 10.
    Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol. 2000;169(1–2):123–31.PubMedCrossRefGoogle Scholar
  11. 11.
    Green DM, Kawashima T, Stovall M, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009;27(16):2677–85.PubMedCrossRefGoogle Scholar
  12. 12.
    Meirow D, Epstein M, Lewis H, et al. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod. 2001;16(4):632–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Petrek JA, Naughton MJ, Case LD, et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol. 2006;24(7):1045–51.PubMedCrossRefGoogle Scholar
  14. 14.
    Gracia CR, Sammel MD, Freeman E, et al. Impact of cancer therapies on ovarian reserve. Fertil Steril. 2012;97(1):134–40.e1.PubMedCrossRefGoogle Scholar
  15. 15.
    Wallace WH, Thomson AB, Saran F, et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738–44.PubMedCrossRefGoogle Scholar
  16. 16.
    Signorello LB, Mulvihill JJ, Green DM, et al. Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study. Lancet. 2010;376(9741):624–30.PubMedCrossRefGoogle Scholar
  17. 17.
    Meistrich ML, Finch M, da Cunha MF, et al. Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res. 1982;42(1):122–31.PubMedGoogle Scholar
  18. 18.
    Green DM, Kawashima T, Stovall M, et al. Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2010;28(2):332–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Hansen PV, Hansen SW. Gonadal function in men with testicular germ cell cancer: the influence of cisplatin-based chemotherapy. Eur Urol. 1993;23(1):153–6.PubMedGoogle Scholar
  20. 20.
    Pryzant RM, Meistrich ML, Wilson G, et al. Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin’s lymphomas. J Clin Oncol. 1993;11(2):239–47.PubMedGoogle Scholar
  21. 21.
    Sandeman TF. The effects of x irradiation on male human fertility. Br J Radiol. 1966;39(468):901–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Hahn EW, Feingold SM, Simpson L, et al. Recovery from aspermia induced by low-dose radiation in seminoma patients. Cancer. 1982;50(2):337–40.PubMedCrossRefGoogle Scholar
  23. 23.
    Centola GM, Keller JW, Henzler M, et al. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl. 1994;15(6):608–13.PubMedGoogle Scholar
  24. 24.
    Berthelsen JG, Skakkebaek NE. Gonadal function in men with testis cancer. Fertil Steril. 1983;39(1):68–75.PubMedGoogle Scholar
  25. 25.
    Sanger WG, Armitage JO, Schmidt MA. Feasibility of semen cryopreservation in patients with malignant disease. JAMA. 1980;244(8):789–90.PubMedCrossRefGoogle Scholar
  26. 26.
    Spermon JR, Ramos L, Wetzels AM, et al. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer. Hum Reprod. 2006;21(7):1781–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Viviani S, Ragni G, Santoro A, et al. Testicular dysfunction in Hodgkin’s disease before and after treatment. Eur J Cancer. 1991;27(11):1389–92.PubMedCrossRefGoogle Scholar
  28. 28.
    Domingo J, Guillen V, Ayllon Y, et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril. 2012;97(4):930–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Oktay K, Kim JY, Barad D, et al. Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol. 2010;28(2):240–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Dillon KE, Sammel MD, Prewitt M, et al. Pretreatment antimullerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy. Fertil Steril. 2013;99(2):477–83.e1.PubMedCrossRefGoogle Scholar
  31. 31.
    von Wolff M, Montag M, Dittrich R, et al. Fertility preservation in women – a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet. 2011;284(2):427–35.CrossRefGoogle Scholar
  32. 32.
    Baynosa J, Westphal LM, Madrigrano A, et al. Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. J Am Coll Surg. 2009;209(5):603–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Fertility Experts Issue New Report on Egg Freezing; ASRM Lifts Experimental Label from Technique. 2012.Google Scholar
  34. 34.
    Cao YX, Chian RC. Fertility preservation with immature and in vitro matured oocytes. Semin Reprod Med. 2009;27(6):456–64.PubMedCrossRefGoogle Scholar
  35. 35.
    Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2011;96(2):277–85.PubMedCrossRefGoogle Scholar
  36. 36.
    Smith GD, Serafini PC, Fioravanti J, et al. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil Steril. 2010;94(6):2088–95.PubMedCrossRefGoogle Scholar
  37. 37.
    Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;1(8486):884–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Kuleshova L, Gianaroli L, Magli C, et al. Birth following vitrification of a small number of human oocytes: case report. Hum Reprod. 1999;14(12):3077–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Cobo A, Kuwayama M, Perez S, et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril. 2008;89(6):1657–64.PubMedCrossRefGoogle Scholar
  40. 40.
    Parmegiani L, Cognigni GE, Bernardi S, et al. Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes. Reprod Biomed Online. 2011;23(4):505–12.PubMedCrossRefGoogle Scholar
  41. 41.
    Rienzi L, Romano S, Albricci L, et al. Embryo development of fresh ‘versus’ vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod. 2010;25(1):66–73.PubMedCrossRefGoogle Scholar
  42. 42.
    Rienzi L, Cobo A, Paffoni A, et al. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod. 2012;27(6):1606–12.PubMedCrossRefGoogle Scholar
  43. 43.
    Friedler S, Koc O, Gidoni Y, et al. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril. 2012;97(1):125–33.PubMedCrossRefGoogle Scholar
  44. 44.
    Acevedo B, Gomez-Palomares JL, Ricciarelli E, et al. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil Steril. 2006;86(6):1682–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26(16):2630–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91(10):3885–90.PubMedCrossRefGoogle Scholar
  47. 47.
    Nayak SR, Wakim AN. Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation. Fertil Steril. 2011;96(1):e51–4.PubMedCrossRefGoogle Scholar
  48. 48.
    von Wolff M, Thaler CJ, Frambach T, et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril. 2009;92(4):1360–5.CrossRefGoogle Scholar
  49. 49.
    Chian RC, Gilbert L, Huang JY, et al. Live birth after vitrification of in vitro matured human oocytes. Fertil Steril. 2009;91(2):372–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Benkhalifa M, Demirol A, Menezo Y, et al. Natural cycle IVF and oocyte in-vitro maturation in polycystic ovary syndrome: a collaborative prospective study. Reprod Biomed Online. 2009;18(1):29–36.PubMedCrossRefGoogle Scholar
  51. 51.
    Fadini R, Dal Canto MB, Mignini Renzini M, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online. 2009;19(3):343–51.PubMedCrossRefGoogle Scholar
  52. 52.
    Andersen CY, Kristensen SG, Greve T, et al. Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients. Future Oncol. 2012;8(5):595–608.PubMedCrossRefGoogle Scholar
  53. 53.
    Oktay K. Evidence for limiting ovarian tissue harvesting for the purpose of transplantation to women younger than 40 years of age. J Clin Endocrinol Metab. 2002;87(4):1907–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Andersen CY, Rosendahl M, Byskov AG, et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod. 2008;23(10):2266–72.PubMedCrossRefGoogle Scholar
  55. 55.
    Dittrich R, Lotz L, Keck G, et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril. 2012;97(2):387–90.PubMedCrossRefGoogle Scholar
  56. 56.
    Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364(9443):1405–10.PubMedCrossRefGoogle Scholar
  57. 57.
    Donnez J, Jadoul P, Pirard C, et al. Live birth after transplantation of frozen-thawed ovarian tissue after bilateral oophorectomy for benign disease. Fertil Steril. 2012;98(3):720–5.PubMedCrossRefGoogle Scholar
  58. 58.
    Donnez J, Silber S, Andersen CY, et al. Children born after autotransplantation of cryopreserved ovarian ­tissue. a review of 13 live births. Ann Med. 2011;43(6):437–50.PubMedCrossRefGoogle Scholar
  59. 59.
    Donnez J, Squifflet J, Jadoul P, et al. Pregnancy and live birth after autotransplantation of frozen-thawed ovarian tissue in a patient with metastatic disease undergoing chemotherapy and hematopoietic stem cell transplantation. Fertil Steril. 2011;95(5):1787.e1–4.CrossRefGoogle Scholar
  60. 60.
    Ernst E, Bergholdt S, Jorgensen JS, et al. The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue. Hum Reprod. 2010;25(5):1280–1.PubMedCrossRefGoogle Scholar
  61. 61.
    Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med. 2005;353(3):318–21.PubMedCrossRefGoogle Scholar
  62. 62.
    Revelli A, Marchino G, Dolfin E, et al. Live birth after orthotopic grafting of autologous cryopreserved ovarian tissue and spontaneous conception in Italy. Fertil Steril. 2013;99(1):227–30.PubMedCrossRefGoogle Scholar
  63. 63.
    Roux C, Amiot C, Agnani G, et al. Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation. Fertil Steril. 2010;93(7):2413.e15–9.CrossRefGoogle Scholar
  64. 64.
    Sanchez-Serrano M, Crespo J, Mirabet V, et al. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Fertil Steril. 2010;93(1):268.e11–3.CrossRefGoogle Scholar
  65. 65.
    Silber S, Kagawa N, Kuwayama M, et al. Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril. 2010;94(6):2191–6.PubMedCrossRefGoogle Scholar
  66. 66.
    Dolmans MM, Marinescu C, Saussoy P, et al. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116(16):2908–14.PubMedCrossRefGoogle Scholar
  67. 67.
    Greve T, Clasen-Linde E, Andersen MT, et al. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;120(22):4311–6.PubMedCrossRefGoogle Scholar
  68. 68.
    Salle B, Demirci B, Franck M, et al. Long-term follow-up of cryopreserved hemi-ovary autografts in ewes: pregnancies, births, and histologic assessment. Fertil Steril. 2003;80(1):172–7.PubMedCrossRefGoogle Scholar
  69. 69.
    Schmidt KT, Rosendahl M, Ernst E, et al. Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: the Danish experience. Fertil Steril. 2011;95(2):695–701.PubMedCrossRefGoogle Scholar
  70. 70.
    Shaw JM, Bowles J, Koopman P, et al. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod. 1996;11(8):1668–73.PubMedCrossRefGoogle Scholar
  71. 71.
    Le Floch O, Donaldson SS, Kaplan HS. Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin’s disease. Cancer. 1976;38(6):2263–8.PubMedCrossRefGoogle Scholar
  72. 72.
    Lee CL, Lai YM, Soong YK, et al. Laparoscopic ovariopexy before irradiation for medulloblastoma. Hum Reprod. 1995;10(2):372–4.PubMedGoogle Scholar
  73. 73.
    Morice P, Castaigne D, Haie-Meder C, et al. Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fertil Steril. 1998;70(5):956–60.PubMedCrossRefGoogle Scholar
  74. 74.
    Wallace WH, Shalet SM, Tetlow LJ, et al. Ovarian function following the treatment of childhood acute lymphoblastic leukaemia. Med Pediatr Oncol. 1993;21(5):333–9.PubMedCrossRefGoogle Scholar
  75. 75.
    Meirow D, Rabinovici J, Katz D, et al. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing ­hormone-releasing hormone agonist and depo-medroxyprogesterone acetate. Cancer. 2006;107(7):1634–41.PubMedCrossRefGoogle Scholar
  76. 76.
    Bedaiwy MA, Abou-Setta AM, Desai N, et al. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil Steril. 2011;95(3):906-141.e1–4.Google Scholar
  77. 77.
    Chen H, Li J, Cui T, et al. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev. (11):CD008018.Google Scholar
  78. 78.
    Ohl DA, Wolf LJ, Menge AC, et al. Electroejaculation and assisted reproductive technologies in the treatment of anejaculatory infertility. Fertil Steril. 2001;76(6):1249–55.PubMedCrossRefGoogle Scholar
  79. 79.
    Tur-Kaspa I, Segal S, Moffa F, et al. Viagra for temporary erectile dysfunction during treatments with assisted reproductive technologies. Hum Reprod. 1999;14(7):1783–4.PubMedCrossRefGoogle Scholar
  80. 80.
    Brinster RL. Male germline stem cells: from mice to men. Science. 2007;316(5823):404–5.PubMedCrossRefGoogle Scholar
  81. 81.
    Brook PF, Radford JA, Shalet SM, et al. Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation. Fertil Steril. 2001;75(2):269–74.PubMedCrossRefGoogle Scholar
  82. 82.
    Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol. 2002;187(4):1070–80.PubMedCrossRefGoogle Scholar
  83. 83.
    Winther JF, Boice Jr JD, Svendsen AL, et al. Induced abortions in Danish cancer survivors: a population-based cohort study. J Natl Cancer Inst. 2009;101(9):687–9.PubMedCrossRefGoogle Scholar
  84. 84.
    Patel A, Schwarz B. Cancer and contraception. Release date May 2012. SFP Guideline #20121. Contraception. 2012;86(3):191–8.PubMedCrossRefGoogle Scholar
  85. 85.
    Carver JR, Shapiro CL, Ng A, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25(25):3991–4008.PubMedCrossRefGoogle Scholar
  86. 86.
    Group CsO. Healthy Living after Treatment for Childhood Cancer. 2008 [December 10, 2012]. Available from
  87. 87.
    van Dalen EC, van der Pal HJ, van den Bos C, et al. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines. Eur J Cancer. 2006;42(15):2549–53.PubMedCrossRefGoogle Scholar
  88. 88.
    O’Sullivan JM, Huddart RA, Norman AR, et al. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol. 2003;14(1):91–6.PubMedCrossRefGoogle Scholar
  89. 89.
    Blakely LJ, Buzdar AU, Lozada JA, et al. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer. 2004;100(3):465–9.PubMedCrossRefGoogle Scholar
  90. 90.
    Green DM, Sklar CA, Boice Jr JD, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2374–81.PubMedCrossRefGoogle Scholar
  91. 91.
    Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol. 2008;26(5):753–8.PubMedCrossRefGoogle Scholar
  92. 92.
    Dew JE, Wren BG, Eden JA. A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer. Climacteric. 2003;6(1):45–52.PubMedGoogle Scholar
  93. 93.
    Castelo-Branco C, Rovira M, Pons F, et al. The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation. Maturitas. 1996;23(3):307–12.PubMedCrossRefGoogle Scholar
  94. 94.
    Gracia CR. Reproductive health after cancer. Cancer Treat Res. 2010;156:3–9.PubMedCrossRefGoogle Scholar
  95. 95.
    Canada AL, Schover LR, Li Y. A pilot intervention to enhance psychosexual development in adolescents and young adults with cancer. Pediatr Blood Cancer. 2007;49(6):824–8.PubMedCrossRefGoogle Scholar
  96. 96.
    Neese LE, Schover LR, Klein EA, et al. Finding help for sexual problems after prostate cancer treatment: a phone survey of men’s and women’s perspectives. Psychooncology. 2003;12(5):463–73.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations